Abstract
Purpose of Review
Biopsy-negative rejection is a condition defined by a cardiac dysfunction with a left ventricular ejection fraction (LVEF) ≤ 45% with normal histology and with the absence of other causes of cardiac allograft damage. The purpose of this review is to determine the incidence of biopsy-negative rejection, the therapeutics, and the outcome in the light of new techniques of evaluation or detection of acute rejection in heart-transplanted patients. Although rare, many physicians have once experienced this difficult situation. Even though it is considered the gold standard for the diagnosis of rejection, pathology is of limited help in biopsy-negative rejection by definition.
Recent Findings
Showed advances made in the field of transplant medicine, such as cardiovascular magnetic resonance imaging, noninvasive biomarkers, and molecular assessment using transcriptomic analysis of the cardiac allograft tissue on endomyocardial biopsies.
Summary
Biopsy-negative rejection marks the limit of histology; new techniques developed to improve the follow-up of heart transplant recipients could be of future help in the understanding of biopsy-negative rejection and maybe dethrone the biopsy for the diagnostic of acute rejection.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Ponikowski P. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016;37:2129–200.
Lund L, Kush K, Cherikh W, Goldfarb S, Kucheryavaya A, Levvey B, et al. The registry of the International Society for Heart and Lung Transplantation: thirty-fourth adult heart transplantation report-2017. J Heart Lung Transplant. 2017;36:1039–46.
Fischbein C, Kobashigawa J. Biopsy-negative cardiac transplant rejection: etiology, diagnosis, and therapy. Curr Opin Cardiol. 2004;19:166–9.
Tang Z, Kobashigawa J, Raffei M, Stern L, Hamilton M. The natural history of biopsy-negative rejection after heart transplantation. J Transp Secur. 2013;2013:1–6. https://doi.org/10.1155/2013/236720.
Caves P, Coltram J, Billingham M, Rider A, Stinson E. Transvenous endomyocardial biopsy-application of a method for diagnosis heart disease. Postgrad Med J. 1975;51:286–90.
Costanzo M. The International Society of Heart and Lung Transplantation: guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2010;29:914–56.
Stewart S, Winters G, Fischbein M, Tazelaar H, Kobashigawa J, Abrams J, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant. 2005;24:1710–20.
Berry G, Burke M, Andersen C, Bruneval P, Fedrigo M, Fischbein M, et al. The 2013 International Society for Heart and Lung Transplantation working formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation. J Heart Lung Transplant. 2013;32:1147–62.
Boilson B, Miller D, Pereira N. Late allograft failure after heart transplantation: 2 unusual cases. J Heart Lung Transplant. 2008;27:1050–4.
Chih S, Tinckam K, Ross J. A survey of current practice for antibody-mediated rejection in heart transplantation. Am J Transplant. 2013;13:1069–74.
Butler C, Savu A, Bakal J, Toma M, Thomson R, Chow K, et al. Correlation of cardiovascular magnetic resonance imaging finding and endomyocardial biopsy results in patients undergoing screening for heart transplant rejection. J Heart Lung Transplant. 2015;34:643–50.
Van Heeswijk R, Piccini D, Tozzi P, Rotman S, Meyer P, Schwitter J, et al. Three-dimensional self-navigated T2 mapping for the detection of acute cellular rejection after orthotopic heart transplantation. Transplant Direct. 2017;3:e149. https://doi.org/10.1097/TXD.0000000000000635.
Bonnemains L, Cherifi A, Girerd N, Odile F, Feblinger J. Design of the DRAGET study: a multicentre controlled diagnostic study to assess the detection of acute rejection in patients with heart transplant by means of T2 quantification with MRI in comparison to myocardial biopsies. BMJ Open. 2015;5:e008963. https://doi.org/10.1136/bmjopen-2015-008963.
Kobashigawa J, Patel J, Azarbal B, Kittelson M, Chang D, Czer L, et al. Randomized pilot trial of gene expression profiling versus heart biopsy in the first year after heart transplant. Circ Heart Fail. 2015;8:557–64.
Duong Van Huyen JP, Tible M, Gay A, Guillemain R, Aubert O, Varnous S, et al. MicroRNA as non-invasive biomarkers of heart transplant rejection. Eur Heart J. 2014;35:3194–202.
Grskovic M, Hiller D, Eubank L, Sninsky J, Christopherson C, Collins J, et al. Validation of a clinical-grade assay to measure donor-derived cell-free DNA in solid organ transplant recipients. J Mol Diagn. 2016;18:890–902.
Sharon E, Shi H, Kharbanda S, Koh W, Martin L, Khush K, et al. Quantification of transplant-derived circulating cell-free DNA in absence of a donor genotype. PLoS Comput Biol. 2017;13:e1005629. https://doi.org/10.1371/journal.pcbi.1005629.
•• Loupy A, Duong Van Huyen JP, Hidalgo L, Reeve J, Racape M, Aubert O, et al. Gene expression profiling for the identification and classification of antibody-mediated heart rejection. Circulation. 2017;135:1–19. This study evaluates for the first time how to read endomyocardial biopsy from a molecular approach.
Mengel M, Sis B, Kim D, Chang J, Famulski K, Hidalgo L, et al. The molecular phenotype of heart transplant biopsies: relationship to histopathological and clinical variables. Am J Transplant. 2010;10:2105–15.
• Halloran P, Potena L, Duong Van Huyen JP, Bruneval P, Leone O, Kim D, et al. Building a tissue-based molecular diagnostic system in heart transplant rejection: the heart molecular microscope diagnostic (MMDx) system. J Heart Lung Transplant. 2017;36:1192–200. This article introduces the notion of heart molecular microscope diagnostic analyzing rejection-associated transcript
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Thoracic Transplantation
Rights and permissions
About this article
Cite this article
Epailly, E., Chenard, MP. & Van Huyen, JP.D. Biopsy-Negative Rejection: a Rare but Difficult Issue in Heart Transplantation. Curr Transpl Rep 5, 231–234 (2018). https://doi.org/10.1007/s40472-018-0206-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40472-018-0206-9